AstraZeneca to Pay $34 Million Settlement Over Texas Medicaid Kickback Allegations
AstraZeneca has agreed to a $34 million settlement with the Texas attorney general over allegations that it provided improper incentives to boost prescriptions covered by Texas Medicaid.
The state alleged the drugmaker offered a free network of nurses and insurance-support services to influence prescribing decisions, actions that would normally be handled or paid for by physicians.
According to the complaint, these practices prompted pharmacies and pharmacy-benefit managers to file Medicaid claims for AstraZeneca medicines, resulting in reimbursements that the state says were not authorized under Texas fraud prevention laws.
This writeup was produced by pharmadog from original reporting by STAT.
Original headline: “STAT+: AstraZeneca to pay $34 million to settle kickback charges filed by Texas attorney general”
read at STAT ↗
comments(0)
5-min edit window · permanent after that